Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-007199
Filing Date
2025-02-21
Accepted
2025-02-21 17:05:56
Documents
1
Period of Report
2025-02-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1740175550.html 4  
1 FORM 4 wk-form4_1740175550.xml 4 3084
  Complete submission text file 0001628280-25-007199.txt   4784
Mailing Address 223 N. MATHILDA AVE. SUNNYVALE CA 94086
Business Address 223 N. MATHILDA AVE. SUNNYVALE CA 94086 (650) 938-6300
23andMe Holding Co. (Issuer) CIK: 0001804591 (see all company filings)

EIN.: 871240344 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 490 HILL STREET APT 5 SAN FRANCISCO CA 94114
Business Address
Selsavage Joseph Anthony (Reporting) CIK: 0001943360 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39587 | Film No.: 25652969